ArticleJMA journal2026
Delayed Minocycline Initiation from Symptom Onset and Severe Outcomes in Japanese Spotted Fever: A Single-Center Retrospective Study in Eastern Hiroshima, Japan.
Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Japanese spotted fever (JSF) is an endemic tick-borne rickettsiosis in Japan that can cause severe illness and organ failure. Because early tetracycline therapy is crucial for improving outcomes, clarifying the clinical profile of JSF in endemic communities with an aging population and quantifying the impact of treatment delay are clinically important. We aimed to describe the clinical characteristics of patients with polymerase chain reaction (PCR)-confirmed JSF in an endemic region and to evaluate whether delays from symptom onset to minocycline initiation were associated with severe outcomes. Methods: We conducted a retrospective cohort study in patients with PCR-confirmed JSF admitted to a tertiary hospital in eastern Hiroshima Prefecture between 2011 and 2023. Time intervals were calculated using calendar dates, with same-day events coded as 0 days. The primary outcome was severe JSF, defined as the need for invasive mechanical ventilation and/or renal replacement therapy. Logistic regression was used to assess associations between onset-to-minocycline delay and severe outcomes, adjusting for age and sex. Results: Forty-two patients (median age, 73.5 years) were included. Severe outcomes occurred in 13 patients (31.0%), and 6 patients (14.3%) died during hospitalization. The median onset-to-minocycline interval was longer in severe cases than in non-severe cases (6.0 vs. 4.0 days; p = 0.035). In multivariable analysis, each 1-day delay in minocycline initiation was associated with higher odds of severe outcomes (adjusted odds ratio, 1.35; 95% confidence interval, 1.01-1.81; p = 0.043). Conclusions: In this region with endemic JSF and with an older patient population, longer delays from symptom onset to minocycline initiation were associated with severe outcomes. Strategies to shorten onset-to-treatment intervals, including timely clinical examination and empiric tetracycline therapy when JSF is suspected, may improve outcomes in older communities with endemic JSF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.